Prognostic value of β1,6-branched oligosaccharides in human colorectal carcinoma

Cancer Research

Volumn 58, Issue 23, 1998, Pages 5559-5564

  Seelentag, Walter K F ^a   Li, Wei Ping ^a   Schmitz, Shu Fang Hsu ^b   Metzger, Urs ^b   Aeberhard, Peter ^b   Heitz, Philipp U ^a   Roth, Jürgen ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b SWISS GROUP FOR CLINICAL CANCER RESEARCH SAKK   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

LECTIN; LEUKOAGGLUTININ; OLIGOSACCHARIDE; PHYTOHEMAGGLUTININ;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; COLORECTAL CARCINOMA; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOCHEMISTRY; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TUMOR GROWTH; CLINICAL TRIAL; COLORECTAL TUMOR; CONFORMATION; DISEASE FREE SURVIVAL; IMMUNOHISTOCHEMISTRY; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; PATHOLOGY; PREDICTION AND FORECASTING; PROSPECTIVE STUDY; STAINING;

ADULT; AGED; CARBOHYDRATE CONFORMATION; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; OLIGOSACCHARIDES; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; STAINING AND LABELING;

EID: 0032222421     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Dennis, J. W. Changes in glycosylation associated with malignant transformation and tumor progression. In: M. Fukuda (ed.), Cell Surface Carbohydrates and Cell Development, pp. 161-194. Boca Raton, FL: CRC Press, 1992.
2. Hakomori, S. Tumor malignancy defined by aberrant glycosylation and sphingo(glyco)lipid metabolism. Cancer Res., 56: 5309-5318, 1996.
3. Kobata, A. Cancer cells and metastasis. The Warren-Glick phenomenon: a molecular basis of tumorigenesis and metastasis. In: J. Montreuil, J. F. G. Vliegenthart, and H. Schachter (eds.), Glycoproteins and Disease, pp. 211-227. Amsterdam: Elsevier, 1996.
4. Yamashita, K., Ohkura, T., Tachibana, Y., Takasaki, S., and Kobata, A. Comparative study of the oligosaccharides released from baby hamster kidney cells and their polyoma transformant by hydrazinolysis. J. Biol. Chem., 259: 10834-10840, 1984.
5. Yamashita, K., Tachibana, Y., Ohkura, T., and Kobata, A. Enzymatic basis for the structural changes of asparagine-linked sugar chains of membrane glycoproteins of baby hamster kidney cells induced by polyoma transformation. J. Biol. Chem., 260: 3963-3969, 1985.
6. Pierce, M., and Arango, J. Rous sarcoma virus-transformed baby hamster kidney cells express higher levels of asparagine-linked tri-and tetraantennary glycopeptides containing [GlcNAc-β(1,6)Man-α(1,6)Man] and poly-N-acetyllactosamine sequences than baby hamster kidney cells. J. Biol. Chem., 261: 10772-10777, 1986.
7. Dennis, S. W., Lafert, S., Waghorne, C., Breitman, M. L., and Kerbel, R. S. β 1-6 branching of Asn-linked oligosaccharides is directly associated with metastasis. Science (Washington DC), 236: 582-584, 1987.
8. Dennis, J. W., Kosh, K., Bryce, D. M., and Breitman, M. Oncogenes conferring metastatic potential induce increased branching of Asn-linked oligosaccharides in rat2 fibroblasts. Oncogene, 4: 853-860, 1989.
9. Lu, Y., and Chaney, W. Induction of N-acetylglucosaminyltransferase V by elevated expression of activated or proto-Ha-ras oncogenes. Mol. Cell. Biochem., 122: 85-92, 1993.
10. Dennis, J. W. Effects of swainsonine and polyinosinic-polycytidilic acid on murine tumor cell growth and metastasis. Cancer Res., 46: 5131-5136, 1986.
11. Humphries, M. J., Matsumoto, K., White, S. L., and Olden, K. Oligosaccharide modification by swainsonine treatment inhibits pulmonary colonization by B16-F10 murine melanoma cells. Proc. Natl. Acad. Sci. USA, 83: 1752-1756, 1986.
12. Demetriou, M., Nabi, I. R., Coppolino, M., Dedhar, S., and Dennis, J. W. Reduced contact-inhibition and substratum adhesion in epithelial cells expressing GlcNAc-transferase V. J. Cell Biol., 130: 383-392, 1995.
13. Cummings, R., and Kornfeld, S. Characterization of the structural determinants required for the high affinity interaction of asparagine-linked oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating and erythroagglutinating lectins. J. Biol. Chem., 257: 11230-11234, 1982.
14. Bierhuizen, M., Edzes, H., Schiphorst, W., van den Eijinden, D., and Dijk, W. Effects of α2-6 linked sialic acid and α1-3 linked fucose on the interaction of N-linked glycopeptides and related oligosaccharides with immobilized Phaseolus vulgaris leukoagglutinating lectin (L-PHA). Glycoconj. J., 5: 85-97, 1988.
15. Takano, R., Nose, M., Nishihira, I., and Kyogoku, M. Increase of β1-6 branched oligosaccharides in human esophageal carcinomas invasive against surrounding tissue in vivo and in vitro. Am. J. Pathol., 137: 1007-1011, 1990.
16. Dennis, J. W., and Lafert, S. Oncodevelopmental expression of -GlcNAc β1,6 Man α1,6Man β1,6-branched asparagine-linked oligosaccharides in murine tissues and human breast carcinomas. Cancer Res., 49: 945-950, 1989.
17. Fernandes, B., Sagman, U., Auger, M., Demetriou, M., and Dennis, J. W. β 1-6 branched oligosaccharides as a marker of tumor progression in human breast and colon neoplasia. Cancer Res., 51: 718-723, 1991.
18. Chammas, R., Cella, N., Marques, L. A., Brentani, R. R., Hynes, N. E., and Franco, E. L. F. Letter to the editor. Cancer Res., 54: 306-307, 1994.
19. Li, W. P., Zuber, C., Heitz, P. U., and Roth, J. Cytochemical staining for beta 1,6 branching of asparagine-linked oligosaccharides in variants of metastatic human colon carcinoma cells. Am. J. Pathol., 145: 470-480, 1994.
20. Laffer, U. T. for Swiss Group for Clinical Cancer Research. Long-term results of single course of adjuvant intraportal chemotherapy for colorectal cancer. Lancet, 345: 349-353, 1995,
21. Dukes, C. E. Histological grading of rectal cancer. Proc. R. Soc. Med., 30: 371-376, 1937.
22. Grinnell, R. S. The grading and prognosis of carcinoma of the colon and rectum. Ann. Surg., 109: 500-533, 1939.
23. Sobin, L. H., and Wittekind, C. TNM classification of malignant tumors. New York: John Wiley & Sons, Inc., 1997.
24. Jass, J. R., Atkin, W. S., Cuzick, J., Bussey, H. J., Morson, B. C., Northover, J. M., and Todd, I. P. The grading of rectal cancer: historical perspectives and a multivariate analysis of 447 cases. Histopathology, 10: 437-459, 1986.
25. Jass, J. R., Love, S. B., and Northover, J. M. A new prognostic classification of rectal cancer. Lancet, 350: 1303-1306, 1997.
26. Li, W. P., Zuber, C., and Roth, J. Use of Phaseolus vulgaris leukoagglutinating lectin in histochemical and blotting techniques: a comparison of digoxigenin-and biotin-labeled lectins. Histochemistry, 100: 347-356, 1993.
27. Roth, J., Zuber, C., Sata, T., and Li, W-P. Lectin-gold histochemistry on paraffin and Lowicryl K4M sections using biotin and digoxigenin-conjugated lectins. In: J. M. Rhodes, and J. D. Milton (eds.), Methods in Molecular Biology Series, pp. 41-53. Totowa, NJ: Humana Press, 1998.
28. Li, W. P., and Roth, J. Expression of β1,6 branched asparagine-linked oligosaccharides in non-mitotic and non-migratory cells of normal human and rat tissues. Int. J. Cancer, 71: 483-490, 1997.
29. Cuzick, J. A Wilcoxon-type test for trend. Stat. Med., 4: 87-90, 1985.
30. Tulsiani, D. R., Harris, T. M., and Touster, O. Swainsonine inhibits the biosynthesis of complex glycoproteins by inhibition of Golgi mannosidase II. J. Biol. Chem., 257: 7936-7939, 1982.
31. Olden, K., Breton, P., Grzegorzewski, K., Yasuda, Y., Gause, B. L., Oredipe, O. A., Newton, S. A., and White, S. L. The potential importance of swainsonine in therapy for cancer and immunology. Pharmacol. Ther., 50: 285-290, 1991.
32. VanderElst, I., and Dennis, J. W. N-linked oligosaccharide processing and autocrine stimulation of tumor cell proliferation. Exp. Cell Res., 192: 612-621, 1991.
33. Goss, P. E., Baptiste, J., Fernandes, B., Baker, M., and Dennis, J. W. A Phase I study of swainsonine in patients with advanced malignancies. Cancer Res., 54: 1450-1457, 1994.
34. Lemaire, S., Derappe, C., Michalski, J. C., Aubery, M., and Neel, D. Expression of beta 1-6-branched N-linked oligosaccharides is associated with activation in human T4 and T8 cell populations. J. Biol. Chem., 269: 8069-8074, 1994.
35. Granowski, M., Fode, C., Warren, C. E., Campbell, R. M., Marth, J. D., Pierce, M., Fregien, N., and Dennis, J. W. GlcNAc-transferase V, and core 2 GlcNAc-transferase expression in the developing mouse embryo. Glycobiology, 5: 797-806, 1995.
36. Perng, G. S., Shoreibah, M., Margitich, I., Pierce, M., and Fregien, N. Expression of N-acetylglucosaminyltransferase V mRNA in mammalian tissues and cell lines. Glycobiology, 4: 867-871, 1994.
37. Li, W. P., Komminoth, P., Zuber, C., Klöppel, G., Heitz, P. U., and Roth, J. Can malignancy in insulinomas be predicted by the expression patterns of beta 1,6 branching of asparagine-linked oligosaccharides and polysialic acid of the neural cell adhesion molecule? Virchows Arch., 429: 197-204, 1996.
38. Dennis, J. W., Koch, K., Yousefi, S., and VanderElst, I. Growth inhibition of human melanoma tumor xenografts in athymic nude mice by swainsonine. Cancer Res., 50: 1867-1872, 1990.
39. Seelentag, W. K. F., Böni, R., Günthert, U., Futo, E., Burg, G., Heitz, P. U., and Roth, J. Expression of CD44 isoforms and β1,6 branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J. Cutan. Pathol., 24: 206-211, 1997.